Human EXOSC3 activation kit by CRISPRa

CAT#: GA109494

EXOSC3 CRISPRa kit - CRISPR gene activation of human exosome component 3



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
EXOSC3 mouse monoclonal antibody, clone OTI1D6 (formerly 1D6)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


EXOSC3 (Myc-DDK-tagged)-Human exosome component 3 (EXOSC3), transcript variant 1
    • 10 ug

CNY 2,400.00
CNY 4,465.00


EXOSC3 mouse monoclonal antibody, clone OTI4C9 (formerly 4C9)
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol EXOSC3
Locus ID 51010
Kit Components

GA109494G1, EXOSC3 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA109494G2, EXOSC3 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA109494G3, EXOSC3 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001002269, NM_016042
Synonyms bA3J10.7; CGI-102; hRrp-40; p10; PCH1B; RRP40; Rrp40p
Summary This gene encodes a non-catalytic component of the human exosome, a complex with 3'-5' exoribonuclease activity that plays a role in numerous RNA processing and degradation activities. Related pseudogenes of this gene are found on chromosome 19 and 21. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jun 2012]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...